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Abstract
Background: Physical activity (PA) has health benefits for people with type 2 diabetes (T2D). Indeed, regular PA is
considered an important part of any T2D management plan, yet most patients adopt a sedentary lifestyle.
Exercise referral schemes (ERS) have the potential to effectively promote physical activity among T2D patients, and
their effectiveness may be enhanced when they are supported by computer-based technologies.
The ‘TRIPL-A’ study (i.e., a TRIal to promote PhysicaL Activity among patients in the young-old age affected by T2D)
aims to assess if realizing an innovative ERS, based on a strong partnership among general practitioners, specialist
physicians, exercise specialists, and patients, and supported by a web-based application (WBA), can effectively lead
sedentary older T2D patients to adopt an active lifestyle.
Methods: A randomized controlled design will be used, and an ERS, supported by a WBA, will be implemented.
300 physically inactive T2D patients (aged 65–74 years) will be assigned to either an intervention or control arm.
Control arm patients will only receive behavioral counseling on physical activity and diet, while intervention arm
patients will also undergo an 18-month (3 day/week), discontinuously supervised aerobic exercise training program.
The trial will be divided into six three-month periods: during first, third and fifth period, an exercise specialist will
supervise the training sessions and, using the WBA, prescribe exercise progression and monitor exercise adherence.
Patients will exercise on their own in the other periods.
Patients’ sedentary behaviors (primary outcome), PA level, fitness status, metabolic profile, psychological well-being,
quality of life, and use of health care services (secondary outcomes) will be assessed at baseline and at 6, 12, and
18 months from baseline.
Repeated measure ANCOVAs will be used to compare the intervention and control arm with respect to each study
outcome measure.
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Discussion: Primary and secondary outcome results will allow us to evaluate the effectiveness of an ERS, specifically
designed for the management of T2D clinical conditions and supported by a WBA, in promoting PA within Italian
primary care settings.
Trial registration: This trial is retrospectively registered under the Australian New Zealand Clinical Trials Registry
(reference number: ACTRN12618001164280; registered 13 July 2018).
Keywords: Diabetes mellitus type 2, Exercise training, Sedentary lifestyle, Habits, Older, Quality of life, Randomized
controlled trial, Patient compliance, Exercise referral scheme, Computer-based intervention
Background
The baby boomer generation, one among the largest co-
horts of history, is approaching retirement age and the
maintenance of the health status and independence of
this aging segment of the population (i.e., ≥ 65 years) is
currently a major public health concern [1].
Regular physical activity (PA) is one of the main predictors
of health and well-being in older people, whereas sedentary
behaviors and physical inactivity are associated with an in-
creased risk of over 20 health conditions, including heart
diseases, cancer, stroke, and diabetes [2]. Indeed, PA has
proven positive effects on people who have stable chronic
diseases, such as diabetes, helping to reduce the risk of dis-
ability and the use of health care services. Structured PA is
now considered an important part of type 2 diabetes (T2D)
management plan [3] since it improves blood glucose con-
trol and well-being, while reducing diabetes-related compli-
cations and cardiovascular risk factors. In addition, reducing
sedentary behavior and interrupting prolonged sitting are
also recommended to improve blood glucose levels in adults
with T2D [4] and such measure have come to be viewed as
critical to effective T2D management [5]. In fact, reducing
daily sitting time has been shown to yield marked improve-
ments of diabetes clinical goals [6], even when PA engage-
ment is accounted for.
However, despite the well-known benefits of PA and
reduced sitting time, most older people adopt a seden-
tary lifestyle and evidence-based interventions promot-
ing PA largely fail to be translated into practice [7, 8].
This is particularly true for T2D patients, who show
low levels of physical activity, high levels of sedentary
behaviors [9], and a disappointing low participation rate
in diabetes education classes [10]. Indeed, long-term
diabetic education interventions do not often yield sig-
nificant improvements in blood glucose control, regard-
less of whether they are peer-led in community-based
settings [11] or administered by previously trained gen-
eral practitioners (GP) in clinical settings [12, 13]. Fur-
thermore, existing studies on this topic mostly focus on
middle-aged patients, while the literature on older T2D
patients is scant (see [14] for a review).
Poor integration among the stakeholders in disease pre-
vention is one of the major causes of the low effectiveness
of PA promotion [15]. The literature has shown that exer-
cise referral scheme (ERS) interventions – in which health
care professionals refer patients who will benefit from PA
to third party services that prescribe and monitor an exer-
cise program tailored to their individual needs – may rep-
resent an effective model to promote PA in primary care
settings [16, 17]. Specifically, a report from the UK Na-
tional Institute for Health Research [18] clearly shows that
primary care-based ERSs designed for T2D patients lead
to a significant improvement in glucose control and a
reduction in diabetes complications compared to a
non-active intervention comparator. Promoting regular
PA in older T2D patients could therefore represent a
cost-effective strategy to improve the management of their
health condition and their quality of life, while reducing
the burden of health care resources. Indeed, findings from
other studies (e.g., see [19, 20]) suggest that patients that
are referred to PA by GPs are more likely to be active than
those who are referred by a visiting specialist. Interest-
ingly, studies have also suggested that the effectiveness of
interventions aimed at promoting PA, in both healthy
adults [21, 22] and T2D patients [23, 24], may be en-
hanced when traditional methods are supported by the
use of web-based applications (WBA).
To our knowledge, long-term studies implementing an
ERS supported by web-based technologies aiming to im-
prove the management of the clinical conditions of older
T2D patients have never been conducted in Italy.
Methods
Objectives
The ‘TRIPL-A’ study (i.e., a TRIal to promote PhysicaL
Activity among patients in the young-old age affected by
type 2 diabetes) aims to assess if realizing an innovative
ERS based on a strong partnership among GPs, specialist
physicians, exercise specialists, and patients, and sup-
ported and facilitated by a multi-platform WBA, can ef-
fectively lead older sedentary T2D patients to adopt an
active lifestyle.
We hypothesize that this ERS will be able to reduce
inactivity time and the use of healthcare resources.
Accordingly, the primary objective of the trial is to de-
termine if the ERS reduces sedentary behaviors, while
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the secondary objectives are to determine if it increases
the patient’s physical activity level, fitness status, meta-
bolic profile, psychological well-being, and quality of life,
while reducing the use of health care services.
Design
The ‘TRIPL-A’ is a randomized, controlled, open, bicenter
trial, with two parallel groups. The study will be carried
out in two urban areas (independent in terms of staff, fa-
cilities and participants) in the Marche region (Central
Italy): the Diabetology Unit of the IRCCS-INRCA Hospital
in Ancona and the Diabetology Unit of the ASUR Hospital
of Fabriano (AN). Enrolled patients will be assigned to ei-
ther the intervention or control arm. The assessments will
be performed within the medical facilities, while the exer-
cise training program will be carried out within third party
fitness facilities. An overview of the study is shown in
Fig. 1.
Participants’ eligibility
Older T2D patients who meet the inclusion criteria and
wish to participate voluntarily will have to sign a written
informed consent form before being recruited and any
trial procedure occurs. No procedures will be performed
until the patient has signed the consent form and been
accepted into the trial. Only recruited patients who do
not meet any of the exclusion criteria will be enrolled
and will participate in the trial.
Trial staff must withdraw enrolled patients at any time
if they no longer meet the inclusion and exclusion
criteria.
Inclusion criteria
Patients who meet all of the following criteria will be
recruited:
- age range (years): 65 to 74;
- suffering from T2D according to ADA criteria [25];
- physically inactive or insufficiently active (i.e., level 1
or level 2 exposure to physical inactivity) according to
the WHO framework of health risks quantification [26],
as assessed using the results of the International Phys-
ical Activity Questionnaire (IPAQ) short form.
Exclusion criteria
Patients who will meet one or more of the following cri-
teria will not be enrolled:
- receiving β-blockers therapy or any other drug that
could affect heart rate, either at rest or in response to
aerobic exercise;
- suffering from chronic obstructive pulmonary
disease;
- terminally ill (life expectancy < 6 months);
- suffering from severe cardiovascular disease (includ-
ing New York Heart Association class III or IV
congestive heart failure), clinically significant valvular
disease, history of cardiac arrest, presence of an implant-
able defibrillator, or uncontrolled angina that would
interfere with the ability to participate fully in either
study arm;
- history of myocardial infarction, transient ischemic
attack or stroke in the six months before the recruitment
date;
- suffering from any condition that, in the clinical
judgement of the principal investigator, might harm the
patient if he or she were to participate in the trial.
ERS and WBA implementation
The ERS to be used in the present study is a physical ac-
tivity promotion and adoption framework delivered
through primary care institutions and implemented
within third party facilities. The ERS starts with a GP
referral of the eligible T2D patient to the specialist phys-
ician of the Diabetology Unit, who will assess her/his
clinical status and, in turn, refers the patient to the exer-
cise specialist of the third party facility. The exercise
specialist will design a personalized exercise program
based on the patient’s medical needs and her/his clinical
status, both of which will be provided by the specialist
physician. The ERS will also provide feedback through a
WBA specifically designed for the study, which will
allows the specialist physician and the GP to monitor
the adherence of each patient to the exercise prescrip-
tion made by the exercise specialist.
The WBA will be developed and made available on
the Web to patients and trial staff. The WBA will be de-
signed to serve as both the framework on which the ERS
is based, and the platform where data are recorded,
stored, processed and used by the investigators for the
purposes of the trial. Above all, the WBA is designed to
enhance and foster the partnership among the study
stakeholders, who will have different roles and be based
in different locations. In fact, its web-based nature will
allow the different stakeholders to access, via a
web-browser (therefore regardless the the device used
and/or its form factor), to the contents made available
according to the privileges granted to each user. All the
enrolled patients will have access to generic pages pro-
moting an active lifestyle, providing physical activity and
healthy diet guidelines and other useful information on
how to self-manage T2D in older adults. Patients en-
rolled in the intervention arm will also be able to access
data generated from their own training (such as adher-
ence to the protocol, average aerobic exercise intensity
and duration, motivational feedback based on their
training results, etc.). Those data will be made available
by the WBA after the automatic processing of the
exercise training data entered by the exercise specialists,
who will have read and write privileges for all the
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non-clinically relevant information and all the exercise
session report forms of the enrolled patients. GPs and
specialist physicians will have access to both the clinical,
non-clinical and exercise session data of all the patients
they refer to the trial. They will therefore be able to
monitor the patient’s adherence to the trial (according to
the specific requirements of the study arm to which the
patient has been assigned) and readily obtain the infor-
mation needed to give the patient motivational feedback
to improve compliance. The WBA will also allow inves-
tigators to store and access patients’ clinically and
non-clinically relevant data (copies of patients’ case re-
port forms, test results, and compliance reports; timeline
of the trial; randomization; etc.) and to set the range of
values of the exercise prescription parameters of the
whole training intervention. The WBA will use both the
parameters of the exercise prescription and those result-
ing from each training session in order to constantly
provide an updated profile of each patient in the inter-
vention arm. The profile can then be used by the exer-
cise specialists to adjust the exercise type, duration and
intensity for the subsequent training session. Finally, the
Fig. 1 Study design
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principal investigator will have full privileges, including
the ability to export all the data stored in the WBA on-
line database in files to be imported into statistical
software.
Exercise referral and recruitment strategies
When making referrals, participating GPs and specialist
physicians will first screen their patients using the inclu-
sion criteria and then send their contact details to the
trial staff for enrollment.
The following promotional initiatives will be
implemented:
- providing GPs working near the trial areas of the trial
with informative material on healthy lifestyle (see below)
and asking them to participate in the trial by adopting
the ERS; participating GPs will then provide their T2D
patients with information on the trial and refer them to
the TRIPL-A;
- distributing fliers in the clinical centers and facilities
involved in the trial;
- displaying posters in the clinical centers and facilities
involved in the trial.
Healthy lifestyle informative material
TRILP-A staff will create and make available an “active
lifestyle leaflet”, whose purpose is to promote PA in
older T2D patients, and a “healthy eating brochure”,
whose purpose is to help T2D patients to improve their
dietary habits. For this purpose infographic materials
from the “Handbook for Canada’s physical activity guide
to healthy active living” [27] will be translated into Ital-
ian and modified according to the needs of this trial.
The healthy eating brochure will help diabetic patients
to improve their dietary habits by balancing meal nutri-
ents composition and making healthy food choices.
Enrollment and arm assignment
A total of 300 older T2D patients will be enrolled and ran-
domly assigned to either the control or the intervention
arm with a 1:1 ratio, using a computerized permuted
blocks randomization. The randomizations will be per-
formed using a code created by the statisticians of the
INRCA Biostatistical Center, who will not be involved in
any other part of the trial. Allocation concealment will be
assured because the trial staff will not know the
randomization code and procedures (e.g., block sizes), and
the allocation will be made only after the termination of
all baseline tests (see Fig. 1).
Due to the obvious differences between the interven-
tions (see below), neither staff nor participants will be
blinded to group allocation. However, before data ana-
lysis, patient allocations and identification numbers will
be replaced by categorical variables whose meaning will
be unknown to data analysts.
Intervention
Trial intervention will last 18 months during which time
concomitant care will be permitted. Patients of both trial
arms will be retained as long as they meet the inclusion
and exclusion criteria.
Intervention arm
Patients assigned to the intervention arm will receive the
healthy lifestyle informative material and a behavioral
counselling on physical activity and diet by a trained
physician. The healthy lifestyle informative material will
be given to the patients during the behavioral counseling
and discussed.
A structured exercise program of 18months, with al-
ternating three-month periods of supervised and
non-supervised training (i.e., discontinued supervision),
will be implemented. Participants will train three times
per week, with at least 48 h between each exercise
session.
During the 3 three-month periods of supervised train-
ing (period 1: 1st to 3rd month; period 3: 7th to 9th
month; period 5: 13th to 15th month), patients will exer-
cise at a fitness center under the supervision of an exer-
cise specialist, who will use the WBA to constantly
monitor and update the exercise prescription. In the
non-supervised training periods (period 2: 4th to 6th
month; period 4: 10th to 12th month; period 6: 16th to
18th month) participants will train on their own and use
the WBA to access their aerobic training schedule and
parameters (duration and intensity). They will also be
asked to enter the actual workout performed into the
WBA at the end of each self-monitored exercise session.
The aerobic exercise training protocol will be designed
according to the internationally accepted recommenda-
tions and guidelines on health-enhancing PA for older
adults [28–30] and T2D patients [31–34].
Aerobic exercise intensity will be prescribed and moni-
tored according to heart rate (HR), which is a reliable
parameter in the present trial since patients will not be
taking any medication that could affect it. For each pa-
tient, the percentage of target HR (%HRtarget) prescribed
for a given exercise period will be applied to the HR
reserve (HRR), i.e. the difference between resting HR
(HRrest) and maximum HR (HRmax). Patients’ HRrest will
be directly measured, whereas the HRmax will be esti-
mated according to the equation proposed by Gellish et
al. [35]. For each patient, the exercise session target HR
(HRtarget) will then be calculated (in beats per minute) as
follows: HRtarget = [(HRmax – HRrest) x %HRtarget] +
HRrest. This approach, namely the “HRR method” [36], is
widely accepted as the most accurate in establishing a
HRtarget because, I) it accurately reflects the percentages
of the reserve values of oxygen uptake (V̇O2R), i.e. the
gold standard for assessing the relative metabolic
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intensity, and II) it allows the correction of the exercise
intensity for the HRrest, which can be highly variable
among subjects [37].
Supervised exercise
Aerobic exercise intensity and duration will gradually
increase throughout each three-month period (see
Table 1).
At the end of each session, the exercise specialist will
prescribe the exercise duration and intensity of the next
session, aiming for a progression rate that will allow
patients to reach the upper limit range of each
three-month period at least one week before its end.
The WBA will help the exercise specialist to implement
the progression rate by highlighting: 1) when the patient
has completed two consecutive training sessions; 2) the
duration and intensity of the previous sessions; 3) the
pattern of the previous increases in duration and inten-
sity (in order to alternate the type of increment); 4) the
type of exercise (e.g. treadmill, bike, etc.) performed in
the previous sessions (which will also be alternated).
The 10-point category ratio scale (CR-10) of perceived
exertion [38] will also be also used to monitor exercise
intensity. In order to familiarize participants with the
scale, the exercise specialist will 1) provide them with
standardized instructions on how to use it, and 2)
anchor the upper limit of the scale to a specific feeling
experienced in the past during intense PA sessions
(i.e., anchoring memory procedure).
Non-supervised exercise
Aerobic exercise intensity and duration achieved at the
end of each supervised three-month period will be used
as a reference for the subsequent non-supervised period
(see Table 2). Patients will choose the type of aerobic ex-
ercise independently but will be required to adhere to
the exercise intensity and duration prescribed for that
particular three-month period. When patients are not be
able to monitor their own exercise HR while exercising,
they will be required to control for exercise intensity by
trying to achieve the same rate of perceived exertion of
the last session of the previous supervised training
period. They will also be asked to enter exercise dur-
ation, average HR and perceived exertion into the WBA
after each training session.
Control arm
Patients assigned to the control arm will only receive the
healthy lifestyle informative material and a behavioral
counselling session on physical activity and diet by a
trained physician. The healthy lifestyle informative ma-
terial will be discussed with the patients and handed out
to them during the behavioral counselling session.
Intervention adherence
Three main strategies will be used to improve intervention
adherence throughout the trial. Firstly, the healthy lifestyle
informative material will be handed out and discussed with
all participants at every follow-up. Secondly, periodic feed-
back (about twice during each three-month period) will be
given to the intervention arm participants (by e-mail and/
or by telephone). The feedback will be based on training
adherence data retrieved from the WBA: acceptable adher-
ence will be reinforced, whereas participants whose adher-
ence has decreased will be provided with motivational
inputs. Lastly, intervention arm patients will be contacted
by phone each time they attend one fewer session per week
than expected for two consecutive weeks.
Assessments/outcomes
Patients’ anthropometrics, sedentary habits, PA level, fit-
ness status, metabolic profile, psychological well-being,
quality of life, and use of health-care resources will be
assessed, along with other routine assessments, on four
separate occasions: at baseline and at 6, 12, and 18
months from baseline (see Table 3). The difference be-
tween the intervention and control arms at the
12-month time-point will be considered the main out-
come for each measure.
Primary outcome measure
Sitting time will be retrieved from the results of the
IPAQ short form and computed as average daily minutes
of sitting calculated over a one-week period. The IPAQ
is a well validated tool [39–43] for assessing both habit-
ual sitting time and physical activity engagement. The
IPAQ short form will be interview-administered by
trained personnel.
Secondary outcome measures
Physical activity level and fitness status Metabolic
Equivalents (MET) per week (an index of physical
Table 1 Supervised aerobic training rate of progression for
exercise session intensity and duration parameters
Period 1 Period 3 Period 5
Intensity (%HRR range) 40–50 45–55 50–60
Duration (minute range) 20–30 30–40 40–50
Notes: Values are indicative and will be modified according to patient’s
response to exercise; %HRR, heart rate reserve percentage
Table 2 Non-supervised aerobic training rate of progression for
exercise session intensity and duration parameters
Period 2 Period 4 Period 6
Intensity (%HRR target) 50 55 60
Duration (minutes) 30 40 50
Notes: %HRR, heart rate reserve percentage
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activity level) will be calculated using the IPAQ short
form. Maximal oxygen uptake (V̇O2max; an index of
fitness status) will be calculated using the results of the
Long Distance Corridor Walk (LDCW) test and
expressed as the sex- and age-specific reference percent-
ile for V̇O2max [34]. The LDCW has been validated as a
reliable shuttle test to estimate V̇O2max in subjects
between 60 to 91 years of age [44, 45]: after a warm-up
of two minutes, the participant is asked to walk 10 laps
“as quickly as possible”, over a 20-m course marked with
cones (i.e., 400 m).
Quality of life
Quality of life will be evaluated with the The EuroQol
5-Dimensional questionnaire (EQ-5D-5L), which con-
sists of questions related to five health domains (pain,
mood, mobility, self-care and daily activities), yielding
an overall quality of life score. Participants’ opinion
on their own current health status will also be evalu-
ated using a visual analogue scale ranging from 0
(worst imaginable health status) to 100 (best imagin-
able health status). The EQ-5D-5L is a widely
accepted and standardized tool to measure
health-related quality of life in diabetic subjects [46].
Healthcare resources
Healthcare resources consumption will be evaluated using
a tailored questionnaire, specifically designed for the study
to assess direct medical costs of: outpatients visits to spe-
cialist physicians, hospital admissions, emergency room
visits, use of homecare services, visits to GPs, and use of
medications and laboratory examinations.
Metabolic profile
Blood fasting glucose and glycated hemoglobin (HbA1c)
analyses will be used as indices of glycemic control.
Since these tests are routinely performed on diabetic pa-
tients, they will be retrieved from the patients’ medical
records, selecting the test that was performed closest to
each assessment time-point.
Sleep disorders
Sleep disorders will be evaluated using the Pittsburgh
Sleep Quality Index (PSQI) global score [47] (in which a
Table 3 Timing of study assessments
Screening Visit 1 baseline Visit 2 follow-up 1 Visit 3 follow-up 2 Visit 4 follow-up 3
Weeks from randomization -2 0 24 48 76
Visit window in weeks – + 2 +/− 2 +/− 2 +/− 2
Informed consent X
Demographics X
Inclusion/exclusion criteria X X
Anthropometric measures X X X X
Clinical variables X X X X
Randomization X
Lifestyle counseling X
Lifestyle informative material X
WBA training (only for intervention group) X
Blood pressure X X X X
Registration of laboratory assays X X X X
LDCW X X X X
IPAQ (short form) X X X X
EQ-5D-5L X X
PSQI X X
Healthcare resource consumption X X X X
Events
Adverse events including hypoglycemia X X X X
New diagnoses X X X X
Intervention compliance check X X X
Trial completion X
Notes: LDCW long distance corridor walk, IPAQ International Physical Activity Questionnaire, EQ-5D-5L Euro Quality of Life 5 Dimensional questionnaire, PSQI
Pittsburgh Sleep Quality Index
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score > 5 indicates poor sleep). The PSQI is a widely ac-
cepted tool to measure sleep-wake disturbances in dia-
betic patients. It assesses sleep quality, sleep latency,
sleep duration, sleep efficiency, sleep disturbances, use
of sleep medications, and daytime dysfunction [48].
Anthropometry
Height (head in the Frankfurt plane) and weight (light
clothes, without shoes) will be measured with the
patient standing and body mass index (BMI) will be
calculated (kg/m2). Waist and hip circumference will
be assessed using standard methods (as the average of
triplicate measures) and waist-to-hip ratio (WHR) will
be calculated.
Routine assessments
Systolic (SBP) and diastolic (DBP) blood pressure
(mmHg) will be measured with the patient sitting on a
chair with back support, while HRrest will be recorded as
the average of the last minute out of 10 min of supine
rest [49].
Research staff training
The medical personnel will receive specific training
on how to approach to and communicate with the
patients to maximize the enrollment rate throughout
the recruitment process of the trial. The training will
provide the healthcare professionals with standardized
information that they can share with the patients, fos-
tering effective communication, particularly as regards
the trial aims, allocation procedure and intervention
protocol.
All the investigators will undergo several training ses-
sions specifically designed to familiarize them with the
timing and protocols of all the trial assessments, and the
correct procedures to enter and store patients’ data in
the WBA.
Exercise specialists will receive training on how to
implement and monitor the exercise prescription in
the patients of the intervention arm and on how to
input data and query the exercise session database
within the WBA. They will be also informed about
the risks associated with exercise in older T2D pa-
tients and trained on how to recognize the signs and
symptoms that call for the immediate termination of
the exercise session [34].
Patients training
All patients will receive training on how access the
WBA, retrieve their own data, and enter lifestyle infor-
mation. Patients of the intervention arm will also be
instructed how to enter data of exercise sessions not
performed under the supervision of the exercise special-
ists into the WBA.
Additional information on data collection, management,
and retention
The information collected during the trial will be deper-
sonalized and password-protected, and access to data
will be restricted to the TRIPL-A staff in accordance
with current Italian law (art 13 D.lgs.196/2003). The
complete final dataset will contain no identifying partici-
pant information and its access will only be granted to
TRIPL-A principal investigators.
Paper-based CRFs will be used to record the results of
patient assessments at each time-point (see Fig. 1). CRFs
data will also be entered into the WBA to provide the
information required to design an exercise prescription
tailored to the specific needs of each patient throughout
the trial. This will also provide the trial with both a data
accuracy verification procedure (the WBA will warn the
user when data entry is incorrect or not physiologically
plausible and when missing data are missing) and an
electronic back-up.
Statistical methods
Sample size calculations
The sample size has been calculated to test the hypoth-
esis of no difference in sitting time per day between
intervention and control arms at the 12-month
time-point (2-sided independent sample t-test; statistical
power 0.8; α level of significance 0.05; 1:1 ratio between
intervention and control arm). Given an expected mean
value of sitting time of 500 ± 200 min per day [39, 41–
43], a sample size of 112 participants in each arm will be
necessary to detect a difference of 75 min per day of
mean sitting times between intervention and control
arm. Therefore, it was assumed that a sample size of 300
participants, i.e. 120 in each arm accounting for an
expected drop-out rate of 20%, is appropriate to obtain
the desired statistical power.
Sample size was computed using STATA statistical
software (StataCorp).
Data analyses
Intention to treat analysis will be adopted to account for
possible issues related to noncompliance and missing
outcomes. Data quality and internal consistency will be
assessed ex-post using Cronbach’s alpha. In addition,
automatic routines will be performed on the data to
detect possible outliers, which will be excluded from
further analyses. Explorative univariate and bivariate
data analyses will then be performed.
For each study outcome, the intervention and control
arm will be compared, as the difference between baseline
and 12-month time-point, using independent sample
t-tests. A mixed-design ANOVA will be used to compare
each study outcome between intervention and control
arm at the four different time-points, followed by
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post-hoc pairwise comparisons when a significant inter-
action is found. Participants’ characteristics (e.g., age,
sex, fitness status, physical activity level, and metabolic
profile) will be used as covariates, and appropriate inter-
action terms will be assessed and may be included in the
model. For all tests, 2-sided p values with an α level of
significance of 0.05 will be used. Bonferroni’s criterion
will be used to adjust the overall α level to correct for
multiple tests.
The assumptions of each statistical test will be
assessed before analyses and, if not met, either data
transformation will be performed or alternative statis-
tical methods will be adopted (e.g., GEE, mixed-models,
non-parametric analyses, etc.) will be performed. The
residuals and goodness of fit of the models will also be
examined.
SPSS Statistics (IBM) and R (R Core Team) software
will be used to perform data analyses.
Discussion
There is growing consensus on the central role of PA in
maintaining overall health and quality of life. However,
most T2D patients still adopt sedentary behavior and do
not meet the minimum threshold of PA needed to get
health benefits and manage their chronic clinical
condition.
Given the prevalence of inactivity and sedentary be-
havior among T2D patients, strategies able to promote
PA may play a critical role in public health care, and if
its economic impact is minimized it is more likely that
PA could be made available to patients over time and
even become part of standardized treatment in clinical
settings. ERSs appear to be a promising tool to help
achieve this goal. Indeed, the guidance of the UK Na-
tional Institute for Health and Care Excellence currently
recommends that ERSs be implemented for T2D pa-
tients, even though their evidence-based effectiveness
and cost-effectiveness still need further investigation to
be verified [50]. Moreover, since PA is a complex behav-
ior influenced by several factors [51] that can affect its
adoption and maintenance in different ways, behavior
change strategies able to increase motivation to adopt an
active lifestyle are also recommended [52]. Fortunately,
in the current information and communication technol-
ogy era, behavior change initiatives have new tools at
their disposal: indeed, emerging evidence has shown the
potential of computers, smartphones, and wearables to
boost the motivation to switch to, and maintain, an ac-
tive lifestyle [53–56]. The use of WBAs in treatment
plans for T2D patients has generated particular research
interest [57]. In line with this new approach, the main
novelty of the TRIPL-A study is the implementation of
an ERS, supported by a multi-purpose WBA that can be
accessed by physicians, exercise specialists, and patients
to input data and retrieve relevant information. The
WBA provides support for the exercise referral, but it is
primarily designed around the patients and their needs,
with the aim of motivating them to exercise, while at the
same time monitoring their compliance to prescribed
exercise and adherence to the overall training protocol.
The inclusion of the WBA as an integral part of this trial
fits nicely with the use of a discontinuously supervised
training protocol, making the discontinuous nature of
the protocol one of the particular strengths of the study.
Indeed, the WBA has dual aims: to educate T2D patients
on “how to” train in order to get the clinical benefits of
exercise (supervised periods); to increase their “willing-
ness” to exercise (non-supervised periods). Patients, in
fact, have to enter the exercise parameters into the WBA
at the end of each self-managed training session. Hence,
the actual adherence of the patients to the training
protocol is readily available to the exercise specialists
and physicians, who can monitor the patients and en-
courage them to exercise effectively. Furthermore, inter-
rupting training supervision reduces the burden
associated with the ERS in terms of personnel and facil-
ity costs. This is of paramount importance for the
healthcare systems that have to manage limited budgets
and a growing number of older T2D patients.
Finally, the ERS and the WBA of the TRIPL-A are spe-
cifically designed to provide support for the Italian pri-
mary care settings, aiming to enhance the partnership
among the stakeholders involved in the current manage-
ment of the clinical conditions of T2D patients. The lack
of coordination among stakeholders is a widely acknowl-
edged weak point in the Italian framework. To our
knowledge, this is the first RCT to be carried out with
the aim of evaluating the effectiveness of an ERS in Ital-
ian primary care settings. Moreover, the results of this
study will add data to the scant literature regarding exer-
cise training, PA promotion and engagement, sedentary
behavior and sitting time, and the management of clin-
ical conditions in older T2D patients.
In conclusion, the TRIPL-A study described herein
could pave the way for new healthcare approaches in the
prevention and treatment of T2D. The study is based on
maximizing the potential of ERS, which could become
part of the routinely prescribed interventions (particu-
larly when supported by ad-hoc WBAs), and on shifting
the focus of disease management to patient’s personal
empowerment, the starting point for the development of
new approaches to health care.
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